Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 414

The DOI matches its Crossref record.

Correction: Corrigendum: Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy

Open access
Cui, Guozhen, Shan, Luchen, Guo, Lin, Keung Chu, Ivan, Li, Guohui, Quan, Quan, Zhao, Yun, Meng Chong, Cheong, Zhang, Zaijun, Yu, Pei, Hoi, Maggie Pui Man, Sun, Yewei, Wang, Yuqiang, Lee, Simon MingYuen·2015·Scientific Reports

Abstract

Protein disulfide isomerase (PDI) family members including PDI and ERp57 emerge as novel targets for anti-thrombotic treatments, but chemical agents with selectivity remain to be explored. We previously reported a novel derivative of danshensu (DSS), known as ADTM, displayed strong cardioprotective effects against oxidative stress-induced cellular injury in vitro and acute myocardial infarct in vivo . Herein, using chemical proteomics approach, we identified ERp57 as a major target of ADTM. ADTM displayed potent inhibitory effects on the redox activity of ERp57, inhibited the adenosine diphosphate (ADP)-induced expressions of P-selectin and αIIbβ3 integrin, and disrupted the interaction between ERp57 and αIIbβ3. In addition, ADTM inhibited both arachidonic acid (AA)-induced and ADP-induced platelet aggregation in vitro . Furthermore, ADTM significantly inhibited rat platelet aggregation and thrombus formation in vivo . Taken together, ADTM represents a promising candidate for anti-thrombotic therapy targeting ERp57.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep13509

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 414

Metadata

Authors
Cui, G., Shan, L., Guo, L., Keung Chu, I., Li, G., Quan, Q., Zhao, Y., Meng Chong, C., Zhang, Z., Yu, P., Hoi, M. P. M., Sun, Y., Wang, Y., & Lee, S. M.
Venue
Scientific Reports
Published
2015-09-02
Volume
5
Issue
1
Pages
13509-13509
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2936213937
Cited by
414
References
0
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Correction: Corrigendum: Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy. https://app.cochat.ai/papers/10.1038/srep13509
The paper
Cui, G., Shan, L., Guo, L., Keung Chu, I., Li, G., Quan, Q., Zhao, Y., Meng Chong, C., Zhang, Z., Yu, P., Hoi, M. P. M., Sun, Y., Wang, Y., & Lee, S. M. (2015). Correction: Corrigendum: Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy. Scientific Reports. https://doi.org/10.1038/srep13509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.